2‐Phenyl‐5‐(pyrrolidin‐1‐yl)‐1‐(3,4,5‐trimethoxybenzyl)‐1 <i>H</i> ‐benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c‐Jun N‐terminal kinase

Wei‐Ling Chang(National Taiwan University), Jih‐Hwa Guh(National Taiwan University)
British Journal of Pharmacology
May 3, 2010
10.1111/j.1476-5381.2010.00832.x
Cited by 28

Related Papers

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|Oncotarget|2015|49
Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle
|PLoS ONE|2014|28
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|Frontiers in Oncology|2020|26
<i>Epi</i>-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma
|Oncotarget|2015|11
Mechanism Studies of Antitubulin Agents-mediated MMP Down-regulation and Nitroxoline Repurposing in Human Prostate Cancer Cells
|OhioLink ETD Center (Ohio Library and Information Network)|2015|0